Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies
Physiological Reviews · 01.10.2024 · 104 (4) · 1643-1677
DOI: 10.1152/physrev.00039.2023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.10.2024. Verfasst von Yuanpu Peter Di und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States. Hauptthemen laut MEDLINE: Lung, Antimicrobial Peptides. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 310 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Fondazione Italiana per la Ricerca sulla Fibrosi Cistica, Fondazione per la Ricerca sulla Fibrosi Cistica.
Abstract (Originalsprache)
Representing severe morbidity and mortality globally, respiratory infections associated with chronic respiratory diseases, including complicated pneumonia, asthma, interstitial lung disease, and chronic obstructive pulmonary disease, are a major public health concern. Lung health and the prevention of pulmonary disease rely on the mechanisms of airway surface fluid secretion, mucociliary clearance, and adequate immune response to eradicate inhaled pathogens and particulate matter from the environment. The antimicrobial proteins and peptides contribute to maintaining an antimicrobial milieu in human lungs to eliminate pathogens and prevent them from causing pulmonary diseases. The predominant antimicrobial molecules of the lung environment include human α- and β-defensins and cathelicidins, among numerous other host defense molecules with antimicrobial and antibiofilm activity such as PLUNC (palate, lung, and nasal epithelium clone) family proteins, elafin, collectins, lactoferrin, lysozymes, mucins, secretory leukocyte proteinase inhibitor, surfactant proteins SP-A and SP-D, and RNases. It has been demonstrated that changes in antimicrobial molecule expression levels are associated with regulating inflammation, potentiating exacerbations, pathological changes, and modifications in chronic lung disease severity. Antimicrobial molecules also display roles in both anticancer and tumorigenic effects. Lung antimicrobial proteins and peptides are promising alternative therapeutics for treating and preventing multidrug-resistant bacterial infections and anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
- Department of Biochemical Sciences, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Yuanpu Peter Di, Jenna Marie Kuhn, Maria Luisa Mangoni
Förderung
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- Fondazione Italiana per la Ricerca sulla Fibrosi Cistica
- Fondazione per la Ricerca sulla Fibrosi Cistica
Zitieren
APA
Di, Y. P., Kuhn, J. M., & Mangoni, M. L. (2024). Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies. Physiological Reviews, 104(4), 1643-1677. https://doi.org/10.1152/physrev.00039.2023
Vancouver
Di YP, Kuhn JM, Mangoni ML. Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies. Physiological Reviews. 2024;104(4):1643-1677. doi:10.1152/physrev.00039.2023
BibTeX
@article{Di2024,
author = {Di, Yuanpu Peter and Kuhn, Jenna Marie and Mangoni, Maria Luisa},
title = {Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies},
journal = {Physiological Reviews},
year = {2024},
volume = {104},
number = {4},
pages = {1643--1677},
doi = {10.1152/physrev.00039.2023}
}
EUVIMED